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Summary
Presentation of antigenic peptides by human leukocyte antigen class I molecules is dependent
on peptide transport into the endoplasmic reticulum by the transporters associated with antigen
processing (TAP) (Germain, R. N. 1994. Cell. 76:287-299) . This translocation step is currently
regarded as permissive for all peptides with COON-terminal residues capable of binding to
HLA class I molecules (Momburg, F., J . Roelse, J. C. Howard, G. W. Butcher, G . J. Hammer-
ling, andJ. J. Neefjes. 1994. Nature (Loud.). 367:648-651). In this report, we show that the hu-
man transporter selects peptides according to a binding motif based on the strong effects on
peptide affinity of the three NHZ-terminal positions and the COOH-terminal residues. TAP
favors strongly hydrophobic residues in position 3 (P3) and hydrophobic or charged residues in
P2, whereas aromatic or acidic residues in P1, as well as Pro in P1 and P2, have strong delete-
rious effects. Selection of naturally presented peptides by the transporter is suggested by their
higher average affinity for TAP, as compared to nonselected peptides. The TAP preferences in
the three NHZ-terminal positions correspond to those ofthe vast majority of human leukocyte
antigen class I alleles, but they represent an obstacle for peptide supply to some alleles, e.g., the
B7-like group. We propose that peptides binding to these alleles, and in general, peptides with
TAP affinities below a certain threshold, may be transported as extended precursors .
M
HC class I proteins present short breakdown prod-
ucts of predominantly cytosolic proteins on the cell
surface to cytotoxic T lymphocytes (reviewed in reference
1) . Most of these peptides are supplied to newly assembling
MHC class I proteins by the heteromeric transporter asso-
ciated with antigen processing (TAP)'/TAP2' transporter
complex residing in the membrane of the endoplasmic
reticulum (ER) . Peptide transport by TAP can be studied
using iodinated peptide substrates whose accumulation in
the ER is followed grace to an integrated acceptor sequence
for ER-specific glycosylation (2-4). As an alternative strat-
egy for the study of TAP function, we recently overex-
pressed the human TAP complex in the insect cell/bacu-
lovirus system. In this system, peptide transport by TAP, as
well as direct binding of peptide substrate to the transporter
complex, can be measured (5, 6).
'Abbreviations used in this paper: (32m, R2-rnicroglobulin; DTT, dithiothrei-
tol; ER, endoplasmic reticulum; TAP, transporter associated with antigen
processing.
Although the functional consequences of a polymor-
phism in the rat TAP2 gene clearly demonstrate that TAP
selection can modify the spectrum of peptides presented by
MHC class I molecules (7), it is not clear whether the hu-
man or murine transporters contribute to selection of class
I-presented epitopes. Apart from a preference for peptides
with a length of 8-16 residues (5, 8, 9), the only selectivity
of the transporters known so far concerns the COOH-ter-
minal residue. In this position, the human TAP complex
and one rat allele select hydrophobic and positively charged
amino acids, while the other rat allele and the murine
transporter favor hydrophobic residues only (10, 11) . Since
the COOH-terminal selectivities of murine and human
TAP favor all residues that occur in MHC class I-binding
peptides ofthe respective species, peptide transport by these
transporters has been considered to be essentially permissive
for all potential MHC class binding peptides.
Large variations in apparent TAP affinities of peptides
with identical COOH-terminal residues (5, 12, 13) have
been described, however, suggesting that other peptide po-
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possible deleterious effect of Pro in P1 and P3 (10, 13), pre-
vious studies could not identify the variables in the peptide
sequence that determined distinct peptide affinities forTAP.
We have used the microsomal peptide binding assay to
evaluate the binding affinity of >250 peptides for the hu-
man TAP complex. We have defined a binding motif for
the human transporter and have shown selection according
to this motifamong naturally presented peptides. We have
also shown how the conflict between the TAP motif and
binding motifs for certain HLA class I alleles may be re-
solved by TAP transport ofextended precursors ofpeptides
binding to these HLA class I alleles.
Materials and Methods
Peptides.
￿
The peptides used in this study were from various
sources. 40 (9-mer) peptides with sequences derived from the
hepatitis B virus DNA polymerase and HLA-A2 anchor residues
in P2 and P9, five other peptides (11 or 15 mers) derived from
various other viral protein sequences, and all poly-Ala peptides
(except the poly-Ala variants of the HLA-B27-binding motif)
were either purchased as crude material from Chiron Mimotopes
(Chiron Corp., Victoria, Australia), or they were synthesized and
purified to >95% purity at Cytel as previously described (14) .
Stocks of these peptides were dissolved at 5 or 10 mM in 100%
DMSO. 25 (9 or 10 met) peptides containing HLA-A2 anchor
residues in sequences derived from the human 65-kD glutamic acid
decarboxylase protein were obtained from P. Panina-Bordignon
(Roche Milano Ricerche, Milan, Italy); synthesis andpurification
of these peptides are described elsewhere (15) . These peptides
were dissolved at 2 mM in H2O, in some cases containing 0.01 N
NaOH. Most B27-binding peptides (those used in the QSAR
analysis, six peptides with p53-derived sequences, the HSP89a-
derived peptide, and the poly-Ala variants ofthe B27 motifin Ta-
ble2) have been describedin previous studies (16-18). The31 pep-
tide variants shown in Table 1 (>90%pure and dissolved at 2 mM
in H,O) were obtained from M. Androlewicz (Yale University,
New Haven, CT) (9). The HIV-gag and HIV-reverse tran-
scriptase-derived peptides were obtained from T. Tsomides
(Massachusetts Institute of Technology, Cambridge, MA) (19) .
The HLA-1344 binding peptides are described in reference 20.
Peptides that are not specified above were purchased from Geno-
sys (Cambridge, UK), and they were >70% pure and controlled
for correct sequence by mass spectrometry analysis; these were all
dissolved at 10 mM in 100% DMSO.
HLA Class I a Chain Refolding Assay.
￿
An HLA-1327 a chain
refolding assay was used to determine the affinity of peptides har-
boring B27 anchor residues for HLA-1327 (16-18) . Briefly, HLA-
B27 molecules were purified from lymphoblastoid cell lines and
dissociated into a chains and P2microglobulin (R2m) by alkaline
treatment and gel filtration. Unfolded free heavy chains were
mixed with excess 02m and test peptides, and the amount of as-
sembled peptide/a chain/(32m having formed after a 16-h incu-
bation was detected in a radioimmunoassay as inhibition of the
bindingof12- 11-labeledHLA-A2 a/(3 dimers to an antiserum with
specificity forHLA class I a/R dimers.
Soluble MHC-Peptide Binding Assay.
￿
The affinity ofthe HBV
polymerase-derived peptides for HLA-A2 and the affinities of
poly-Ala peptides containing anchor residues for binding to
HLA-A1, A2.1, A3/11, and A24 fortheir respective HLA class I
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allele were measured in assays based on the inhibition of binding
of a radiolabeled probe peptide to detergent solubilized HLA
molecules, as previously described (14, 21, 22). Briefly, HLA
molecules were isolated from lysates of lymphoblastoid cells by
incubation with solid-phase-coupledHLA class I isotype-specific
mAbs. Purified HLA class I a chains were incubated for 2 d at
room temperature with excess R2m, 1-10 nM iodinated probe
peptide, and various concentrations ofcompetitor test peptide. At
the end of the incubation period, the percent of HLA-bound ra-
dioactivity was determined by size exclusion chromatography. As
a measure of affinity, the molar concentration of test peptide re-
quired for 50% inhibition of binding of the labeled peptide was
calculated based on at least two independent assays.
TAP-Peptide Binding Assay.
￿
The affinity of peptides for the
TAP complex substrate binding site was measured essentially as
describedpreviously (5). Microsomes were prepared from Sf9 in-
sect cells harvested 60-80 h aftercoinfection by recombinant bac-
uloviruses expressing the human TAP1 .A and TAP2.A alleles.
Sucrose gradient-separated microsomes were washed once in
PBS/ I mM dithiothreitol (DTT), resuspended in 1 ml of PBS/
DTT per 6-8 X 10' cells (starting material), and snap frozen in
liquid nitrogen in 200-R1 aliquots. Binding assays were performed
using PBS/DTT supplemented with 2 mM MgCl2 and0.1% dia-
lyzed BSA. Serial dilutions of competitor peptide and 15 lt,l mi-
crosome solution were added to 180 l.tl assay buffer at 4°C in a
microfuge tube. Competitor peptides were generally tested in di-
lutions ranging from 0.1- to 1,000- or from 0.3- to 3,000-fold
molar excess relative to radioactive reporter peptide, with step-
wise increases by a factor of 10. As a reporter peptide, we used
throughout this study R-9-L (RRYNASTEL), whose dissocia-
tion constant for the TAP binding site is 4.1 X 10' M. Unless
otherwise specified, 5 ltl peptide R-9-L (labeled with '251 by the
chloramin T method to a specific activity of -7.5 X 10' cpm/
nM) was added, resulting in a molar concentration of 1251-R-9-L
of^" 100 nM. Immediately after the addition of reporter peptide,
the vesicles were pelleted by centrifugation at 15,000 g for 5 min
at 4°C, washed once in 600 Rl assaybuffer, andfinally counted in
100 RI fresh buffer.
Every assay included a duplicate sample without competitor.
The cpm corresponding to 50% inhibition of specific binding
(I50) were calculated as follows:
150 = 0.95* (S1 + S,)/2 - 0.95* (S1 + S2) /4,
with S1 and S2 being the cpm of the samples without competitor.
The factor 0.95 was introduced to account for the experimentally
determined 5% rate of unspecific binding ofiodinated R-9-L to
control microsomes. The molar concentration of the peptides at
which 50% specific inhibition was obtained (ICS,) was deter-
mined graphically by plotting the cpm in the presence of increas-
ing amounts of competitor on semilogarithmic paper. Under the
conditions specified above, the average IC5, of autologous com-
petitor peptide R-9-Lwas 400 nm. To minimize the influence of
variations between assays performed on different days and with
different batches of reporter peptide or microsomes, affinities are
generally indicated as relative values, i.e., multiples of the molar
excess of unlabeled autologous competitor R-9-L, which was
measured as reference value in all assays.
Chemometric Analysis.
￿
The methods and the choice of substi-
tuted peptides in the QSAR (quantitiative structure activity rela-
tionship) analysis of P3, P5, P6, and P7 have been described pre-
viously (17). The PLS (partial least squares) evaluation of the
relative TAP affinities of the peptides shown in Table 4 was per-
formed using the program GOLPE (23).
Transporter Associated with Antigen Processing-binding MotifResults
Binding Affinity in Insect Cell Microsomes Parallels Transport
Amity in Human Cells. Using insect cell microsomes
overexpressing human TAPl/2 complexes, we have pre-
viously shown that selected competitor peptides display
equivalent relative affinities in peptide binding and trans-
port assays (6). To further validate the binding assay, we
chose to test a series of peptides comprising variants of
The peptides shown in the left column were used as competitors in twoassays. First, they were used to competeagainst ATP-dependent accumula-
tion oflabeledreporter peptide '=51-RRYQKSTEL (used at 50 nM in the assay) in the ER ofstreptolysin O-permeabilizedhuman B cells (Swei).
The results ofthis assay (center column) are takenfrom reference 9, wheretheprocedure is detailed. In this study, the same peptide batches were used
to compete for binding of 1251-R-9-L (RRYQKSTEL, used at 100 nM) to TAPl/2 insect cell microsomes. The right hand column lists the molar
concentration at which the peptides inhibited specific binding of R-9-L by 50%. >100 N .M, specific inhibition of <50%, but >20% at 100 PM
competitor concentration; »100 N.M, specific inhibition of <20% at 100 N.M competitor concentration.
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three peptides known to be naturally presented by HLA-
B27 or A3. The affinity of thesepeptides for TAP had pre-
viously been evaluated independently in an assay measuring
the accumulation of glycosylated reporter peptide in the
ER of streptolysin-O-permeabilized human cells express-
ing normal levels of the transporter (9). As shown in Table
1, the competition efficiencies of the peptides using both
methods were strikingly similar. The rank order of the af-
Table 1.
No.
Comparison ofPeptide Transport in
Peptide
Permeabilized
Length
Human Cells and Peptide Binding to
Sequence
Insect Cell Microsomes
Transport
ICS"
Binding
ICso
/IM /IM
1 Nef7B, natural 10 QVPLRPMTYK 1.2 11
2 -variant 1 10 QAPLRPMTYK 1.3 47
3 -variant 2 10 QVPLRPMTYA 0.4 14
4 -variant 3 9 QVPLRPMTY 0.6 1.6
5 -variant 4 9 VPLRPMTYK >100.0 >>100.0
6 -variant 5 8 VPLRPMTY >100.0 >100.0
7 -variant 6 7 VPLRPMT >100.0 >>100.0
8 -variant 7 10 KYTMPRLPVQ 18 >100.0
9 -variant 8 11 AQVPLRPMTYKA 0.2 0.2
10 -variant 9 10 AVPLRPMTYA 0.5 5.0
11 -variant 10 10 AVAAAAAAAK 2.1 9.4
12 B27 #1, natural 9 GRIDKPILK 2.5 2.7
13 -variant 1 9 GRIDKPILK 2.2 8.2
14 -variant 2 9 GRIDKPILA 1.4 5.4
15 -variant 3 8 RIDKPILK 8.5 >100.0
16 -variant 4 8 GRIDKPIL 4.4 >100.0
17 -variant 5 7 RIDKPIL >100.0 >>100.0
18 -variant 6 9 KLIPKDIRG 18 >>100.0
19 -variant 7 11 AGRIDKPILKA 5.1 19
20 -variant 8 9 ARIDKPILA 0.7 0.5
21 -variant 9 9 ARAAAAAAK 3.0 7.0
22 B27 #3, natural 9 RRYQKSTEL 0.5 0.1
23 -variant 1 9 RRYQKSTEL 0.5 0.4
24 -variant 2 9 RRYQKSTEA 0.3 0.7
25 -variant 3 8 RYQKSTEL >100.0 »100.0
26 -variant 4 8 RRYQKSTE 2.5 11
27 -variant 5 7 RYQKSTE >100.0 »100.0
28 -variant 6 9 LETSKQYRR 1.5 2.3
29 -variant 7 11 ARRYQKSTELA 1.5 2.6
30 -variant 8 9 RRYQKSTEA 0.4 0.2
31 -variant 9 9 ARAAAAAAL 1.2 0.9finities of the variants, the range of peptide concentration
required for 50% inhibition and the ratio of the IC50 of
"good" and "bad" competitors were largely equivalent.
Shortening ofthe starting peptide to 7 or 8 mers, as well as
reversal ofthe sequence (with the exception ofthe reversed
variant ofB27#3, variant 6), led to drastic reductions in af-
finity.
Some minor differences, however, should be noted. Re-
placement of the NHZ-terminal residue (Gln, Gly, Arg;
compare variant 8 or 9 to variant 2) by Ala consistently re-
sulted in increased affinity, and replacement of the second
residue (Val, Arg; natural vs. variant 1) by Ala resulted in
decreased affinity in the binding assay, whereas these
changes induced no or a less pronounced effect in the
transport system. Moreover, an exchange of Lys or Len at
the COOH terminus by Ala (natural vs. variant 2) slightly
increased transport competition, but had the opposite effect
on binding to TAP. While the former discrepancies may be
interpreted as evidence for a somewhat higher sensitivity of
the binding assay, the latter may be caused by a distinct in-
teraction of a COOH-terminal Ala with TAP-unrelated
factors (e.g., substrate degradation or active depletion from
the ER) that may interfere with peptide accumulation in
the ER. Cytosolic or ER-resident factors may also be re-
sponsible for the higher apparent transport affinities ofpep-
tide nef7B and most of its variants; this peptide may act as
an inhibitor of degradation of the reporter peptide, or it
may diminish the active depletion ofit from the ER. Thus,
the peptides generally displayed equivalent competition ef-
ficiencies in the two systems, suggesting identical substrate
specificities of TAP complexes expressed at physiological
levels in the human ER or overexpressed in insect cell mi-
crosomes.
Analysis of Single AminoAcid Substitutions in Poly-Ala Pep-
tides. To study the structural requirements for binding of
peptide ligands to the TAP substrate binding site, we first
tested variants ofan HLA-A2 binding 9-mer poly-Ala pep-
tide (ALAKAAAAV) . Some of the peptides tested in this
and other sets of experiments had purities of <95% (70-
95%). We cannot rule out that observed differences may in
some cases be caused by contaminating sequences. Conclu-
sions drawn in this study are therefore generally based on
observations made with multiple independent sets of sub-
stituted peptides.
As shown in Fig. 1, single amino acid exchanges in the
starting sequence gave rise to variants with relative affinities
for TAP differing by up to 4 logs (compare variant PLA-
KAAA AV to ALAKAAA AY). As expected, substitutions in
the COOH-terminal position had the greatest relative ef-
fect (3 logs). Aromatic hydrophobic were followed by ali-
phatic hydrophobic and then charged residues, while a Gly
led to a loss in affinity. Even closely related amino acids
such as Tyr and Phe or Leu and Val were associated with
distinct binding capacity. Aromatic hydrophobic residues at
the COOH terminus confered higher affinity than aliphatic
ones; for example, a Tyr at the COOH terminus confered
almost 100-fold higher affinity than a Val. Surprisingly,
substitutions in the majority of the other positions also
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could lead to marked alterations in peptide affinity. Strong
deleterious effects were observed for Pro in P1 and P2, and
Asp and (less pronounced) Phe in P1. In contrast, introduc-
tion of aromatic or aliphatic hydrophobic amino acids in
several positions, namely (in order of decreasing gain of af-
finity) in 3, 7, 5, and 6 increased peptide binding capacity.
Only in P4 and P8 did minor changes in affinity result from
any chosen substitution.
To complement the analysis of the HLA-A2-binding
model peptide, we tested variants of peptides containing
several other HLA class I-binding motifs (Table 2) . At the
COOH terminus, the distinct relative affinities of closely
related amino acids were confirmed, and additional delete-
rious effects ofThr and Glu were revealed. Again, aromatic
and, in a less pronounced manner, aliphatic hydrophobic
residues were prefered to hydrophilic amino acids such as
Lys or Ser in P3. Aliphatic hydrophobic residues (especially
Val and Ile) and Arg were favored in P2, in which Pro and
also Gly demonstrated deleterious effects. Finally, the detri-
mental effect of an acidic residue in P1 on peptide affinity
was confirmed in two more peptide sequences. In sum-
mary, substitutions in seven out ofthe nine positions in the
test peptides resulted in gains or losses in peptide affinity, in
some cases drastic. Substitutions in the three NHZ-terminal
positions attained effects ofa magnitude that was similar to
that ofCOOH-terminal substitutions.
Statistical Evaluation of Amino Acid Prevalence in High and
Low Affinity Peptides. To obtain additional evidence of the
structural ligand requirements for high affinity binding to
TAP, we compared the frequency of residues belonging to
chemically defined amino acid groups (Table 3 A) found in
the equivalent position of peptides with high or low affin-
ity for TAP. This analysis was based on the assumption that
residues confering high binding capacity would be over-
represented in the group of peptides with high affinity,
while residues with detrimental effects on binding would
be more prevalent in the group with low affinity. The eval-
uation was performed only on peptides whose sequences
were entirely derived from natural protein sequences,
thereby excluding poly-Ala and modified peptides. The
group ofhigh affinity binders comprised 44 peptides with a
relative affinity of <30; 35 ofthese were 9 mers. The group
of low affinity binders included 44 peptides with a relative
affinity of >100 or undetectable binding capacity; 38 of
these were 9 mers.
To compare the two groups, we first separately calcu-
lated for each position and in each of the two groups of
peptides the percentage of amino acids belonging to one of
the chemical groups shown in Table 3 A relative to the to-
tal number of peptides in the respective group of high or
low affinity binders. The percentage found in the high af-
finity group was then divided by the percentage observed
in the low affinity group. Thus, a value >1 in Table 3 A
indicates a preferential occurrence of an individual amino
acid or a chemically defined group of residues among the
peptides with higher affinity for TAP, and a value <1 indi-
cates a more frequent occurrence among peptides with low
affinity. P2 and P9 were not considered in this analysis,
Antigen Processing-binding Motifsince the majority of the peptides had been selected for the
presence of canonical HLA-A2 anchor residues in these
positions. In peptides with a length of more than nine resi-
dues, only P1, P3, and P4 were included in the statistical
evaluation. Ratios %4 or <0.25 were considered signifi-
cant and are underlined in Table 3 A. Significant favorable
and detrimental effects on affinity, as concluded from these
ratios, are summarized in Table 3 B.
Strongly detrimental as well as favorable effects were ob-
served. The single most significant effect (ratio = 7.1) was
the increased binding capacity of peptides carrying an aro-
matic hydrophobic residue in the third position. Other fa-
vorable effects included Pro or an acidic residue in P6, and
an aromatic hydrophobic amino acid in P7 . Significant un-
favorable effects were found more frequently than favor-
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Figure 1.
￿
Effect of substitutions in
peptide ALAKAAAAV. The nine
panels show the effect on TAP affin-
ity ofsubstitutions by the residue in-
dicatedbelowthe panel; theposition
is indicated above it. Binding affinity
forTAPis expressed on thelogarith-
mic y axis in multiples of the ICso
value obtained for the consensus se-
quence, whose relative affinity was
set at 1 . Labeled R-9-L reporter
peptide was used at 20 nM in all as-
says, and competitor peptides were
used at 0.3-3,000-fold molar excess
(7 nM-70 lLM). The consensus pep-
tide ALAKAAAAV had an average
ICSO of 10.8 p,M. The relative ICS
ofvariants marked by an asterisk was
determined by graphical extrapola-
tion, since 3,000-fold molar excess
ofthese peptides gave <50% inhibi-
tion of binding of
1z'I-R-9-L; these
values are therefore rough approxi-
mations. All variants of individual
positions were tested in thesame assay.
able ones. They included aromatic and acidic residues in
P1, Pro in P1 and P3, Gly in P5 and P6, acidic residues in
P7, and aliphatic hydrophobic residues in P5. Most of the
findings paralleled the observations made with the poly-Ala
peptides. Specifically, the strong effects ofsome residues in
P1 and P3 were confirmed, and P4 and P8 were again
shown to possess little effect on peptide affinity for TAP.
Chemometric Analysis of the Role of Secondary HLA Class
I-Peptide Binding Anchors in TAP-Peptide Interaction. Hav-
ing observed favorable effects resulting from substitutions
in multiple peptide positions, we wondered whether the
relative importance of these substitutions could be deter-
mined. To reduce the complexity of this analysis, we fo-
cused on positions that are known to function as secondary
or auxiliary anchors for binding of peptides to HLA class I
Position 1
1000
too
1000
loo-
I
Position 2
1000-
too
Position 3
U 10 10- 10-
0.1 o.1- 0.1 ~
0.01 0.01- 0.01-
A V K F D* P* F M L N D P* F M A K S E
Position 4 Position 5 Position 6
1000 1000- 1000-
loo too- 100-
U to
1,111,
10- 10-
0.1 0.1- 0.1-
0.01 0.01 0.01
T D P K V C L N Y G E A Y I R P G A
Position 7 Position 8 Position 9
1000- 1000 1000
100- too-
i
100
U 10- 10- to
a1
.Jr
0 .1- 0.1 0.1 -
-F 0.01 0.01 - 0.01-
Y L N P E A F P E G A L Y F L R V N GPoly-Ala peptides with the indicated substitutions in the COOH-terminal or one of the three NH2-terminal positions were used as competitors in
binding assays with 100 nM 125I-R-9-L. Estimated affinities are expressed as multiples of the molar excess of unlabeled competitor peptide R-9-L
that wasrequired for 50% inhibition of specific binding of reporter peptide. The average ICso ofR-9-L in these assays was 400 nM (corresponding
to amolar excess of4). Thus, a relative IC5o of10 corresponds to an IC5o of^"4 RM. Arelative ICSo marked by an asterisk wasdetermined by graph-
ical extrapolation. Under., undetectable, i.e. <20% inhibition of specific binding at highest concentration tested.
molecules. Most HLA class I alleles use P2 and the
COOH-terminal position as main anchors, while one or
several of a group of other positions, namely P3, P5, P6,
and P7 frequently act as auxiliary anchors that increase the
affinity of peptide binding to HLA by interacting with
"secondary pockets" in the peptide-binding site of the
HLA molecule.
To assess the relative importance of substitutions in these
positions, we used a chemometric approach to QSAR (24).
A QSAR analysis entails two steps: first, a statistical method
(25) is used to design a series of peptides (nine peptides in
this case) that represent the most informative combinations
out of all the potential groupings of a chosen number of
amino acid parameters in the selected peptide positions. In
this case, we have chosen theparameters ofhydrophobicity
and side-chain bulk (26), and used four amino acids that
represent the four possible combinations of high and low
values for these parameters: Lys (+/+), Ser (+/-), Phe
(-/+), and Val (-/-). Once the affinity of the selected
peptides for TAP (or, in chemometric terms, the activity of
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the selected structures) is known, a quantitative model for
the relationship between peptide sequence and TAP affin-
ity can be developed in a second step. This model can be
used to predict the affinities ofadditional peptides forTAP.
The affinities of the nine selected peptides (peptides 1-9)
for HLA-1327 and TAP are shown in Table 4 A. All pep-
tides carried anchor residues for HLA-1327 in P2 (Arg) and
P9 (Lys), and Ala in P4 and P8, and Ser in P1 . Several con-
clusions can be drawn from the evaluation of the peptide
affinities for TAP and B27. First, substitutions in the four
concerned positions can alter TAP affinity for peptide by 3
logs (compare peptides 3 and 10). Second, a strongly hy-
drophobic residue in P3 made the by far greatest contribu-
tion to peptide affinity for TAP, followed by a hydropho-
bic residue in P7 and a small side chain in P6; the relative
importance of these factors for TAP affinity is expressed in
Table 4 B as "loadings". Third, the chemometric model
based on the test of peptides 1-9 in binding assays allowed
an almost exact prediction of the TAP affinity of peptide
10 (0.31 instead of the experimentally observed 0.34), un-
Transporter Associated with Antigen Processing-binding Motif
Table 2.
Position
Effect ofAdditional Substitutions
Sequence
in P1, P2, P3, and P9
Relative ICyo
forTAP Position Sequence
Relative IC50
for TAP
1 ARAAAAAAA 10 3 ARFAAAIAKK 0.2
K 152 Y 0.6
V 200 W 0.8
E Undet. I 1.0
AIRLKVFVL 0.9 A 1.7
E 16 V 2.0
K 7.9
2 AVAKAAAAY 0.5 S 8.3
I 0.5
L 1.0 9 ARAAAAAAA 10
Y 1.5 E 1,135*
ARAAAAAAK 24 AYAKAAAAY 1.0
I 46 F 2.3
K 57 L 4.6
L 70 K 23
Y 70 ARAAAAAAR 29
N 109 K 70
T 120 A 114
G 500 Q 188
P 2,174* T 661
ARAAAAAAA 2.1 E 1,875*Table 3.
￿
Relative Frequencies ofResidues in Positions P1-P8 of
Peptides with High or Low TAPAffinity
P
The ratios shown in A were obtained in the following manner: two
groups ofpeptides were formed based on their classification as good to
intermediate binders (relative lC5o of30 or lower, n = 44) or as poor
binders (relative ICS of 100 or higher, n = 44). Foreach peptide posi-
tion, residues belonging to groups of amino acids shown in the left-
hand were counted separately in the two groups. From these numbers,
percentages ofpeptides carrying a particular residue in a specific posi-
tion and in one ofthe two groups were calculated. Finally, the percent-
ages observed in the group of good to intermediate binders were di-
vided by those foundin the group ofpoor binders, resulting in the ratio
shown in the table. Ratios considered significant are underlined. The
significant ratios shown in A are graphically summarized in B. P2 and
P9 were not analyzed since most peptides possessed HLA-A2 anchors in
these positions.
derscoring the validity of the binding assay and the chemo-
metric evaluation. Finally, the properties of the residues in
positions 3, 5, 6, and 7 required for high affinity binding to
TAP and B27 appeared strikingly similar, as demonstrated
by parallel affinity values for the individual peptides and
equivalent loadings (Table 4, A and B) .
The TAP Substrate-binding Site Favors Binding of Peptides
with High Affinitiesfor Certain HLA Class IAlleles. Summa-
rizing the results obtained by the three analytical strategies
used up to this point, all positions known to represent pri-
mary or secondary anchor positions for peptide binding to
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Table 4.
￿
Chemometric Analysis ofP3, P5, P6, and P7
A.
10 SRWAVVWAK 0.05 0.34
In A, the sequences of the peptides chosen for the QSAR analysis and
theiraffinities for B27 and TAPareshown. The relative IC50s forHLA-
B27 were determined in an HLA class I a chain refolding assay. Since
this assay is based on detection of competition, a high value signifies a
low affinity. Affinities for TAP are expressed as multiples of the refer-
ence IC5o ofR-9-L competitor peptide, as described in the legend for
Table 2. In B, the relative contribution of hydrophilicity and shape of
the residues in individual positions to the overall affinity ofthe peptides
forthe B27 or TAP-binding site areexpressedas "loadings." Anegative
hydrophilicity value indicates ahydrophobic amino acid, while a nega-
tive bulk value corresponds to asmallside chain.
HLA class I molecules had been shown to be involved in
determining the affinity for the transporter complex. It was
therefore reasonable to speculate that the distinct require-
ments for high affinity peptide binding to specific HLA
class I alleles may give rise to significant differences in TAP
affinity between peptides bearing particular HLA-binding
motifs. To approach this issue, we first tested a number of
poly-Ala peptides that contained binding motifs for five
different HLA class I alleles (Table 5 A) . All peptides pos-
sessed high or intermediate binding affinities (ICso <500
nM) for their respective HLA allele, as determined in
HLA-peptide binding assays (not shown). Primary (and
secondary for A1 and 1327) anchors for various HLA class I
alleles in a poly-Ala backbone confered clearly different
binding affinities for TAP. The highest affmites were ob-
A.
Position 1 3 4 5 6 7 8 Peptide no. Sequence
ICSO in binding
to HLA-1327
Relative IC50
forTAP
Y, F, W 0.20 7.1 0.69 1.7 1.1 4.4 3.3 p,M
S, T, C 1 .4 1 .6 0.92 2 .5 1 .3 0.69 0.86 1 SRSAKFVAK >30 23
L, V, 1, M 1 .6 0.6 0.71 0.24 0.89 1 .1 0.93 2 SRFAKKFAK 0.27 2.2
A 2.7 0.69 0.34 1 .5 0.37 2.8 0.28 3 SRKAKSSAK >30 >330
P _0 0.25 0.28 2 .3 4.4 2.2 1 .1 4 SRFAFVVAK 0.06 1 .7
G 0.82 0.51 2 _0 _0 0.55 0.92 5 SRVAVKSAK 6 .3 11
Q, N 1 0.34 2.5 0.56 0.55 1 .1 0.37 6 SRSAFFKAK 1 60
R, K, H 1 .9 2.5 1 .7 2 1 .1 0.89 0.89 7 SRFASFKAK 0.24 3.8
E, D 0.20 0.38 1 .2 0.92 4 . 4 4 0.16 1 .7 8 SRKAVSFAK 2 .7 22
9 SRVASVFAK 0.15 5
B.
Increased
affinity
Y
F
W
D, E
P Y, F, W
B.
Hydrophilicity Side-chain bulk
Position 1 3 4 5 6 7 8 Position B27 TAP B27 TAP
Decreased Y P G G D 3 -0.71 -0.80 0.28 0.19
affinity F L E 5 -0.16 0.01 -0.01 -0.14
W V 6 -0.17 -0.08 -0.42 -0.32
E I 7 -0.38 -0 .48 0.31 0.20
D MTable 5.
￿
TAPAmities ofPeptides with High Amitiesfor Various HLA Class IAlleles
A.
(A) The relative IC5,s o£theindicated number ofpoly-Ala peptides bearing anchor residues for the listed HLA alleles were tested. Theamino acid
substitutions performed in anchor positions are indicated in brackets. Each peptide contained only one ofthe bracketedresidues in the indicated po-
sitions, andall peptides were 9 mers. (B) The average relative ICsosof two groups ofpeptides derived from the sequence ofp53 or HBVpolymerase
are shown. In the case ofthe HBV peptides, theindicated average relative ICso was calculated from the values of 11 peptides,since twoofthesepep-
tidesdisplayed no measureable affinity forTAP. (C The binding motifs for HLA-A2 and B27 are depicted as described in reference 14 forA2 andin
references 17 and36 forB27; only anchor positions and the two positions with thenext highest degree ofrestriction areshown. The TAP motiffor
the equivalent positions is compiled from the data in Tables 2 and 3. Residues separated by a slash are associated with equal affinity, while residues
before a semicolonconfer higher affinity than those afterit.
served for those motifs that included aromatic hydrophobic
residues at the position ofa primary (Al, A24) or secondary
(1327) anchor, while anchor residues confering high affinity -
for A2 or A3/11 were associated with markedly lower af-
finity for the TAP-binding site.
Since most of the poly-Ala peptides lacked secondary
anchors naturally found in peptides binding to HLA class I
molecules, we undertook a complementary analysis with
peptides derived from natural protein sequences. This anal-
ysis was performed on six peptides that had been chosen
from the p53 sequence for the presence ofprimary B27 an-
chors (18) and 13 peptides that had been selected from the
sequence of HBV polymerase for the presence of primary
A2 anchors (22). Again, all of these peptides exhibited high
or intermediate affinity for their respective HLA allele. As
shown in Table 5 B, the mean affinities of the two peptide
groups for TAP differed by a factor of >10. Moreover,
two of the A2 binders, but none of the B27 binders, lacked
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any detectable capacity for binding to TAP. In conclusion,
the analysis of peptides derived from natural sequences
confirmed the finding of significant differences between
average TAP affinities of peptides bearing particular bind-
ing motifs for allelic HLA class I products.
An explanation for this difference in average affinities is
provided by a comparison of the binding motifs for HLA-
A2, B27, and TAP. Table 5 C lists the residues associated
with high affinity binding to class I or TAP proteins for the
four positions that are most restricted and most important
for binding in the three biological interactions. With re-
spect to the TAP motif, the A2 motifcontains suboptimal
residues in the anchor positions P2 and P9 and deleterious
amino acids in the auxiliary anchor P1 (see also Table 3),
while the B27 motifis entirely constituted of residues that
confer high affinity for TAP.
The TAPAmities ofNaturally Processed and Presented Pep-
tides.
￿
Having defined a binding motifforthe human pep-
HLA motif Sequence n
Relative IC50
for TAP (mean)
Al A(A,L.T)(D,E)(K.A)AAAAY 8 3.9
A2.01 A(L,M,I)AKAAAA(V,I) 4 31 .6
A3/11 A(L,V,I,T,G)AAAAAA(K,R) 6 73.1
A24 A(Y,F)AKAAAA(F,L) 3 2.3
1327.05 AR(I,A,W,F)AAA(I,A)AK 6 1.6
B.
Relative IC5o
HLA motif Sequence source n for TAP (mean)
1327 p53 6 9.1
A2 HBV polymerase 13 104.5
C.
Position HLA-A2.01 HLA-1327.05 TAP
1 Y/F/W A/G/K/R A;R/K/H
2 L/M R R/V/I;L,Y
3 Y/F/W Y/F/L/I Y/F/W
9 V;I L/F;Y/I/M/R/K Y/F;L/Rtide transporter, we wondered whether any evidence could
be found for selection of peptides according to this motifin
the HLA class I-associated pathway of antigen processing.
We therefore tested the TAP affinities o£ 21 peptides that
are known to be naturally presented by HLA class I mole-
cules (Table 6). None of these peptides were derived from
a signal sequence so that all of them were likely to depend
on translocation by TAP for access to the ER and HLA
class I molecules; only peptide 20 may be generated by
degradation of the CD20 transmembrane protein in the
ER and thus be independent of TAP-mediated transport.
11 peptides (numbers 1, 2, 4, 7-9, 12, 13, 17, 18, and 20)
corresponded to sequences that had been eluted from five
different HLA class I alleles, while the others represented T
cell epitopes known to be presented by HLA-A2 (six pep-
tides), B27, B44, A3, or Aw68. As shown in Table 6, and
in accordance with a recent study (13), naturally processed
peptides displayed awide range of TAP affinities, including
thepeptide with the highest affinity (1) and one ofthe pep-
tides with the lowest affinities (21) among all peptides
tested in this study. Confirming the previous section's con-
clusions, all 1327-presented peptides had high to intermedi-
ate affinities, while some A2-presented peptides displayed
low to unmeasurable affinities.
Peptides are listed in order of decreasing affinity for the TAP-binding site. The sequences known to be presented by HLA class I molecules are
shown in bold type,joined to 6 or more residues that immediately precede them in the natural protein sequences. For peptides 18, 20, and 21, the
sequence andtherelative ICso ofthetested "precursor peptides" are shownin brackets.
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Next, we compared the percentage of peptides with
high, intermediate and low TAP affinities in the group of
naturally processed peptides to the equivalent percentages
in the group of all peptides whose sequence was entirely
derived from a natural protein (Table 7). The most striking
difference between the two groups concerned peptides
with unmeasurable affinities for TAP, which were found
rarely among the naturally processed peptides, but in al-
most a third of the unselected peptides. In addition, the fre-
quency of peptides with high TAP affinities among natu-
rally presented peptides was more than twice greater than
that in the group of unselected peptides. Intermediate to
low affinities for TAP were frequently found among natu-
rally processed peptides . Thus, this comparison suggests
that selection by TAP in class I-associated antigen process-
ing limits ER access to peptides displaying a minimum af-
finity located in the low to intermediate range, and results
in an overrepresentation of peptides with high TAP affini-
ties among naturally presented peptides.
Even though the frequency of low to very low affinity
peptides was reduced among naturally presented sequences,
we were surprised by the apparent permissiveness of TAP-
dependent processing for any such peptide. We speculated
that this phenomenon may be explicable if precursors of
Table 6. TAP
Peptide No.
Affinities of Naturally Presented Peptides
Sequence Source
HLA
restriction
Relative ICS,
forTAP Reference
1 EKFEKEAEMGKGSFY EF-1 B44 0.2 20
2 VALREIRRYQKSTEL Histone H3 B27 0.3 37
3 STLELRSRYWAIRTR Flu NP B27 0.3 37
4 ALNPQNTVFDAKRLIGR Hsc70 A68 0.6 38
5 TQCGYPALMPLYACI HBV pol A2 1.0 39
6 TGSEERSLYNTVATL HIV-gag A2 2.3 19
7 ELFTELAEDKENYKKF HSP90 B44 3.9 20
8 GVVAGGGRIDKPILK Ripoprot. L8 B27 4.7 37
9 TEYLEERRIKEIVKK HSP89a B27 6.7 37
10 FSAGDNPPVLFSSDFRI MAG A2 8.4 40
11 GFPVTPQVPLRPMTYK HIV-nef A3 19 8
12 KTVVKKDVFRDPALK Riboprot. L27 A68 29 38
13 LLPSELTLWVDPYEV TIS21 A2 42 35
14 LAFLQDVMNILLQYM GAD A2 44 15
15 LAQNREILKEPVHGV HIV-RT A2 54 19
16 AGKDPKKTGGPIYKR Flu NP A68 56 38
17 GGKDSASPRYIFTML Topoisom. 2 B7 103 34
18 SGKTYL(SYLLPAIVHI) P68 A2 151(13) 35
19 QNLLQTEENLLDFVRF EBNA3C B44 218 20
20 WKR(TCSRPKSNIVLL) CD20 B7 595(130) 34
21 FTSI(TNFLLSLGIHL) HPV pol. A2 Undet.(45) 39The percentages of peptides with the indicated range ofrelative ICs0s in
the group o£peptides that are known to be naturally processed and pre-
sented were calculated and compared to the percentages in the group
containing peptides, whose sequence was entirely derived from a natu-
ral protein sequence.
such peptides with higher affinities for TAP are translo-
cated into the ER. Intraluminal processing may then gen-
erate the peptides that are known to be presented by HLA
class I proteins. This hypothesis was supported by the anal-
ysis of the TAP affinities of some potential precursor pep-
tides: NHZ-terminal extension of three peptides with very
low or undetectable TAP affinities by one or two residues
yielded precursors with significantly increased TAP affinity
in all of the tested cases (peptides 18, 20, and 21). In sum-
mary, the rare frequency of low affinity peptides among
naturally processed peptides in conjunction with indirect
evidence for a potential transport ofprecursors oflow affin-
ity peptides was compatible with the concept that transport
by TAP contributes to peptide selection in class I-associ-
ated antigen processing.
Discussion
We have defined a binding motiffor the human peptide
transporter. To display high binding capacity, 9-mer pep-
tides need to possess (preferably aromatic) hydrophobic or
charged residues in both the carboxyterminal and the sec-
ond position; moreover, a strongly hydrophobic residue in
P3 and P7 contributes significantly to binding affinity.
Strong detrimental effects on affinity are exerted by Pro in
any ofthe first three positions, by acidic residues in P1, P3,
or P7, and by an aromatic hydrophobic amino acid in P1.
Although this study is likely to have revealed the most sig-
nificant features characterizing peptides with high or low
affinity for TAP, several questions remain to be addressed.
First, we did not test all chemical groups of amino acids in
every position. Second, amino acids belonging to the same
chemically defined group may have different effects, war-
ranting a systematic study of all possible substitutions in all
positions. Third, it will be interesting to study the relative
importance of nonterminal positions in longer peptides. Fi-
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nally, the possibility of mutual interactions between resi-
dues in different positions exists.
Although, in analogy to MHC class I molecules, a binding
motif for the transporter can be defined, peptide binding to
TAP follows rules that appear to be different from peptide
binding to MHC class I molecules (27). Most importantly,
the TAP motif includes positions with a hierarchy of im-
portance, but no "anchor" positions. In all positions (in-
cluding the COOH terminus), the array ofresidues associ-
ated with high or intermediate affinity is larger than in any
class I anchor position. Moreover, deleterious effects of
very unfavorable residues in the relatively most important
positions can be compensated by favorable residues in other
positions. By contrast, such deleterious substitutions in the
anchor positions ofHLA class I motifs lead to complete loss
ofpeptide binding to MHC class I . Thus, TAP seems to act
as a receptor that selects ligands based on the sum of favor-
able and unfavorable interactions.
In a hierarchy of importance of favorable influences on
binding affinity, the COOH terminus appears to be closely
followed by P3 and then P1, P2, and P7 . Thus, the posi-
tions that appear to contribute most to the binding of pep-
tide to TAP are located at both ends of the peptide. It is
tempting to speculate that longer peptides are bound by the
TAP substrate-binding site by interaction with their ter-
mini, while their central portion bulges out from the bind-
ing site.
Like the COOH-terminal preference of human TAP,
the preferences for certain residues in the three NHZ-ter-
minal positions correspond well to those of HLA class I al-
leles, suggesting that the majority of HLA class I-binding
peptides are transported as mature peptides that do not
need further processing. Among the 32 HLA-A, -B, or -C
alleles with known peptide-binding motifs listed in a recent
compilation (28), 25 use aromatic hydrophobic residues as
anchors (nine alleles) or preferred residues (16 alleles) in
position 3. 13 of 21 alleles with known P1 preferences se-
lect Ala, Arg, or Lys, which are also favored by TAP. Resi-
dues prefered by TAP in P2 represent anchors for 14 and
favored residues for three alleles.
However, the preferences of certain HLA class II alleles
for peptide ligands, namely of the B7-like group for Pro in
2 and of A2 for aromates in 1, conflict with those of TAP.
What are the possible consequences of this finding in a cell
expressing various class I molecules? There is no evidence
that the rate ofsurface expression of some HLA alleles is di-
minished because of inefficient TAP-dependent peptide
supply. The TAP motif may, however, influence the de-
gree to which different alleles use a TAP-independent
pathway for peptide supply. Both HLA-A2 and -B7 inter-
estingly present a significant proportion ofpeptides derived
from signal peptides (and therefore with TAP-independent
access to the ER), as shown by peptide elution and se-
quencing experiments (29, 30). As an alternative explana-
tion, peptides derived from signal sequences may be more
likely to correspond to the A2 and B7 motifs .
Although the hypothesis that an increase in presentation
of TAP-independent peptides may compensate for ineffi-
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Table 7. Peptide Affinity Distribution among Naturally Processed
and Unselected Peptides
Naturally
Relative IC50 Unselected processed
for TAP peptides peptides
(n =) % (n =)
>600/Undet. 30.1 (31) 4.7(l)
51-600 19.4 (20) 28.6(6)
5.1-50 35.0 (36) 28.6(6)
0.1-5.0 15.5 (16) 38.1 (8)
Total 100 (102) 100(21)cient HLA allele-specific peptide transport, cannot be ruled
out, we favor an alternative concept: intraluminal process-
ing of precursor peptides in the ER. Intraluminal process-
ing of HLA-bound precursor peptides is suggested by sev-
eral observations . TAP translocates 9-16 mers with equal
efficiency (5, 8, 9, 12), HLA class I molecules binding pep-
tides with a length of up to 40 residues can be detected in
cell lysates (31, 32), and peptide degradation and processing
in the ER have been shown to take place (33). We feel that
the finding of naturally presented peptides with very low
affinities for the transporter lends additional support to this
hypothesis. Moreover, our suggestion ofa transport and in-
traluminal NHZ-terminal processing of extended precursor
peptides is compatible with a recent report showing that a
T cell epitope can be liberated from a longer precursor by
processing in an early secretory compartment by an ami-
nopeptidase activity, but not at all or with much lower effi-
ciency when a carboxypeptidase activity is required (34) .
Furthermore, peptides that are naturally presented by mu-
rine MHC class I molecules and possess very low TAP af-
finities, but potential precursors with higher TAP affinities
have also been found in a recent study by Neisig and coau-
thors (13) . As long as the rules governing the generation of
antigenic peptides in the cytosol are not known, however,
the suggestion of transport of precursor peptides has to re-
main speculative.
Will the knowledge of a TAP-binding motif (possibly
after further refinements) allow us the more precise predic-
tion of HLA class I-restricted T cell epitopes? A need for
further tools in epitope prediction was demonstrated by the
finding that high affinity ofa peptide for a HLA class I mol-
ecule predicts its immunogenicity (as peptide immunogen),
but only partly (in <40% of peptides) its antigenicity (i.e.,
ability to be generated by MHC class I-associated antigen
processing and elicit a response in vivo; 22) . Clearly, pre-
dictions of the antigenic capacity of a peptide based on its
TAP affinity are complicated by the fact that the rules gov-
erning the generation of transportable and presentable pep-
tides in the cytosol are unknown. Iflonger precursors oful-
timately HLA-binding peptides are regularly generated in
the cytosol and then transported by TAP, measurements of
TAP affinities of peptides with high affinites for certain
HLA alleles may not be sufficient for epitope prediction.
Our finding of a relative scarcity of naturally presented
peptides with very low affinities suggests that selection by
TAP acts at the level of the presented peptides, and that
transport of precursors occurs in a minority of cases. Such a
bias for the transport of peptides not needing further pro-
cessing may be imposed by low affinity of precursor pep-
tides for MCI molecules or by a limited efficiency or ca-
pacity of the ER-resident processing system.
What degree ofselectivity does TAP add to MCI-associ-
ated antigen processing? In our selection of peptides with
"natural sequences", -50% had an affinity that failed to
reach the presumed threshold. While the percentage of
peptides with access to the ER is likely to be increased by
posttranslocational processing of precursor peptides, this in-
crease is probably counterbalanced by the loss ofotherpep-
tides with sufficient affinity for TAP, which cannot be gen-
erated in the cytosol and are therefore not available for
transport. It is important to bear in mind that the percent-
age of peptides with low TAP affinities is likely to be
higher among entirely unselected peptides, i.e., peptides
lacking any anchor residue for binding to HLA class I pro-
teins. Although the HLA-A2-binding motif confers an av-
erage TAP affinity that is significantly inferior to the one
confered by the B27 motif, the majority of the residues in
the A2 anchor positions are associated with moderate to
high affinity for TAP. Thus, our panel of "natural pep-
tides" is likely to be biased for high affinity peptides. Even
among this selection of peptides, TAP may exclude at least
halffrom the ER.
Why does TAP impose an additional restriction in the
selection of potentially immunogenic peptides? First, TAP
selectivity may simply represent a byproduct of physical in-
teractions between the transporter and peptides that are re-
quired for sufficient affinity and efficiency of the transport
process. Alternatively, reduction of the spectrum of pep-
tides that are available for presentation by HLA class I mol-
ecules may be useful in limiting the danger of autoimmu-
nity and/or, as recently proposed (35), excessive loss of T
cell repertoire in thymic negative selection, both of which
may be associated with highly efficient processing. Future
studies will show whether the near perfect concordance
between the TAP- and the HLA-1327-binding motif is
purely coincidental or implicated in the role of B27 as the
major HLA class I protein to confer high risk for an au-
toimmune disease.
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